COVID-19 Updates Testing FAQ’s Follow These Leaders Make the switch and integrate better molecular diagnostic collection products, services, and customized solutions for fast project success. Leading & Engineering Life Science Innovation When you engineer and manufacture your own medical device products you not only understand the business, you’re able to offer some pretty valuable added contract manufacturing and MedTech outsourcing benefits including a scaled production capacity model, rapid prototyping, design backed by science, and products like molecular grade nuclease-free water or saline. We deliver – precisely, safely, economically, and yesterday. Products Services Solutions Quality biosamples for medical, genetic, & molecular diagnostic testing start here. The wrong saliva collection device can introduce & increase critical failure points. Technically-superior biosample collection offers the safest & most robust biomaterial–stable, consistent, & secure. Authorized saliva collection delivers greater testing access to a broader population with over 10 days of post-collection stability and no degradation of sample efficacy. VISIT OUR PRODUCT PAGE Partnering with the Right Team Makes Everyone Look Good and everything else look easy. OUR EXPERIENCE Technically-Superior Bio-Sample Collection At Spectrum, our products work harder so you don’t have to. When fast success is what your projects need, consider a single-source, medical device partner and integrate technically-superior product innovation that easily elevates your biosample collection capability and boosts your molecular analysis accuracy. Looking to expand your COVID-19 testing options to include saliva? The SDNA-1000 saliva collection device creates the most robust and safest biomaterial collection approach for the detection of COVID-19 infections and leads the way to a new era of at-home biosample self-collection for the diagnosis of viral infections. PCR testing that incorporates the Spectrum saliva collection kit with patented preservation chemistry identifies infections at their earliest stages from as few as 200 copies/ml compared to lateral flow rapid antigen testing needing 10,000-20,000 copies/ml. (PCR vs. Rapid Antigen Testing Facts) VISIT OUR PRODUCTS PAGE CONTACT US Can we answer any questions? Let's Connect #partofthesolution Ready to Advance your Medical Device Program? © Copyright | Spectrum Solutions™ | All Rights Reserved | Powered by Spectrum Marketing Facebook LinkedIn YouTube